1 2 3 4 5 6 7 8 9

Alzheimer’s Clinical Trial

WVU Rockefeller Neuroscience Institute pioneers promising new Alzheimer’s therapy

An interdisciplinary research team at the West Virginia University Rockefeller Neuroscience Institute became the first in the world to use focused ultrasound to treat a patient with Alzheimer’s disease. If you would like further details regarding the INSIGHTEC ExAblate Neuro Alzheimer’s research study study, please contact the Rockefeller Neuroscience Institute by calling 304-293-5150 or email us at WVURNI@hsc.wvu.edu. The information you provide will not be shared with anyone other than personnel directly involved with the research study.

Dr. Ali Rezai, executive chair of the West Virginia University Rockefeller Neuroscience Institute, lays out his bold, new vision for the neurosciences at WVU. Joining Dr. Rezai are WVU President Gorden Gee, Albert Wright, president and chief executive officer of the West Virginia University Health System, and Clay Marsh, MD, vice president and executive dean for Health Science at WVU.

Research drives patient care at any large academic medical center. As stroke treatment has dramatically evolved in the past decade, WVU Medicine’s neurointerventionists have emerged as national leaders in their relatively new field. Here, Ansaar Rai, M.D., WVU Medicine Radiology vice chair of clinical operations, discusses the past and present of stroke treatment.

Neurosurgeons treat their patients through the use of a delicate, targeted procedure; the best neurosurgeons are skilled at several. WVU Medicine neurosurgeon Robert A. Marsh, MD, PhD, says his best approach is unique to each patient, and considers wishes as well as needs.

WVU Rockefeller Neuroscience Institute